Award
National Cancer Institute 3R01CA274967-04S1
Functional Characterization and Development of Therapeutic Paradigms for DNA Damage Repair (DDR)-deficient Lethal Prostate Cancer
Recipient
Icahn School of Medicine at Mount Sinai
Award Amount
$135,585.00
Ceiling
$135,585.00
Awarded
June 03, 2026
Identifier
3R01CA274967-04S1
Award for research on DDR-deficient lethal prostate cancer focusing on BRCA2 gene alterations and development of targeted therapies such as PSMA radiotherapy and CAR T-cell therapy.
Description
This project aims to investigate the role of DDR gene alterations in prostate cancer, with a focus on BRCA2, and develop targeted therapies including PSMA radiotherapy and CAR T-cell therapy.